Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beacons
- 28 February 2005
- journal article
- case report
- Published by Elsevier in Journal of Clinical Virology
- Vol. 32 (2) , 166-172
- https://doi.org/10.1016/j.jcv.2004.10.007
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A new strategy for studyingin vitro the drug susceptibility of clinical isolates of human hepatitis B virusHepatology, 2004
- YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudineJournal of Viral Hepatitis, 2003
- Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapyJournal of Medical Microbiology, 2002
- The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisationJournal of Clinical Virology, 2002
- A Multicenter Study Evaluation of the Digene Hybrid Capture II Signal Amplification Technique for Detection of Hepatitis B Virus DNA in Serum Samples and Testing of EUROHEP StandardsJournal of Clinical Microbiology, 2000
- A new genotype of hepatitis B virus: complete genome and phylogenetic relatednessMicrobiology, 2000
- Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma PreparationsJournal of Clinical Microbiology, 1999
- Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.The Journal of Infectious Diseases, 1998
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996
- Molecular basis of hepatitis B virus serotype variations within the four major subtypesJournal of General Virology, 1992